Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Hoejberg

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Melanoma Research|June 21, 2012
Interleukin-6 and melanomaLise Hoejberg, Lars Bastholt, Henrik Schmidt
The Journal of Molecular Diagnostics : JMD|March 19, 2013
Low incidence of minor BRAF V600 mutation-positive subclones in primary and metastatic melanoma determined by sensitive and quantitative real-time PCRThomas Kristensen, Ole Clemmensen, Lise Hoejberg
Acta Oncologica (Stockholm, Sweden)|January 20, 2016
Trends in melanoma in the elderly in Denmark, 1980-2012Lise Hoejberg, Dorte Gad, Niels Gyldenkerne, et al.
Melanoma Research|May 24, 2012
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanomaLise Hoejberg, Lars Bastholt, Julia S Johansen, et al.
Seminars in Cancer Biology|April 4, 2021
Multiple endocrine neoplasia type 2: A reviewJes Sloth Mathiesen, Grigoris Effraimidis, Maria Rossing, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2019
The real-world impact of modern treatments on the survival of patients with metastatic melanomaMarco Donia, Eva Ellebaek, Trine Heide Øllegaard, et al.
Cancer Epidemiology|May 7, 2021
The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patientsEva Ellebaek, Inge Marie Svane, Henrik Schmidt, et al.
Cancers|October 19, 2019
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal MelanomaKalijn Fredrike Bol, Eva Ellebaek, Lise Hoejberg, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Melanoma Research|June 21, 2012
Interleukin-6 and melanomaLise Hoejberg, Lars Bastholt, Henrik Schmidt
The Journal of Molecular Diagnostics : JMD|March 19, 2013
Low incidence of minor BRAF V600 mutation-positive subclones in primary and metastatic melanoma determined by sensitive and quantitative real-time PCRThomas Kristensen, Ole Clemmensen, Lise Hoejberg
Acta Oncologica (Stockholm, Sweden)|January 20, 2016
Trends in melanoma in the elderly in Denmark, 1980-2012Lise Hoejberg, Dorte Gad, Niels Gyldenkerne, et al.
Melanoma Research|May 24, 2012
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanomaLise Hoejberg, Lars Bastholt, Julia S Johansen, et al.
Seminars in Cancer Biology|April 4, 2021
Multiple endocrine neoplasia type 2: A reviewJes Sloth Mathiesen, Grigoris Effraimidis, Maria Rossing, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2019
The real-world impact of modern treatments on the survival of patients with metastatic melanomaMarco Donia, Eva Ellebaek, Trine Heide Øllegaard, et al.
Cancer Epidemiology|May 7, 2021
The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patientsEva Ellebaek, Inge Marie Svane, Henrik Schmidt, et al.
Cancers|October 19, 2019
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal MelanomaKalijn Fredrike Bol, Eva Ellebaek, Lise Hoejberg, et al.
Pageof 1